Literature DB >> 8833690

Somatisation in primary care in Spain: I. Estimates of prevalence and clinical characteristics. Working Group for the Study of the Psychiatric and Psychosomatic Morbidity in Zaragoza.

A Lobo, J Garcia-Campayo, R Campos, G Marcos, M J Perez-Echeverria.   

Abstract

BACKGROUND: This is the first attempt to study the prevalence and clinical characteristics of somatisation (ST) in a representative primary care sample in Spain.
METHOD: The sample consisted of 1559 consecutive patients attending eight randomly selected health centres in Zaragoza, Spain, examined by two-phase screening. First phase (lay interviewers): Spanish versions of GHQ-28, CAGE questionnaire, substance abuse, Mini-Mental State Examination. Second phase (research clinicians and psychiatrists): Standardised Polyvalent Psychiatric Interview, which permits the reliable coding of Bridges & Goldberg's ST criteria.
RESULTS: The prevalence of somatisers was 9.4% (34.5% of the cases) and most patients (68.7%) were diagnosed in the depression or anxiety DSM-IV categories. The severity was moderate in 401% and 66.6% were chronic (six or more months). No significant demographic differences were found with non-cases. Backache was the most frequent somatic presentation (71.4+%).
CONCLUSIONS: ST in primary care is a much broader phenomenon than categories such as somatoform disorders reflect. It may be less influenced by sociodemographic factors, but more chronic than previously reported.

Entities:  

Mesh:

Year:  1996        PMID: 8833690     DOI: 10.1192/bjp.168.3.344

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

Review 1.  Somatoform disorders and medically unexplained symptoms in primary care.

Authors:  Heidemarie Haller; Holger Cramer; Romy Lauche; Gustav Dobos
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

2.  Prevalence and correlates of somatoform disorders in the elderly: Results of a European study.

Authors:  Maria Christina Dehoust; Holger Schulz; Martin Härter; Jana Volkert; Susanne Sehner; Anna Drabik; Karl Wegscheider; Alessandra Canuto; Kerstin Weber; Mike Crawford; Alan Quirk; Luigi Grassi; Chiara DaRonch; Manuel Munoz; Berta Ausin; Anna Santos-Olmo; Arieh Shalev; Ora Rotenstein; Yael Hershkowitz; Jens Strehle; Hans-Ulrich Wittchen; Sylke Andreas
Journal:  Int J Methods Psychiatr Res       Date:  2017-02-01       Impact factor: 4.035

3.  Somatisation disorder and its associated factors in multiethnic primary care clinic attenders.

Authors:  E M Khoo; N J Mathers; S A McCarthy; W Y Low
Journal:  Int J Behav Med       Date:  2012-06

4.  Clinical and patient satisfaction outcomes of a new treatment for somatized mental disorder taught to general practitioners.

Authors:  R K Morriss; L Gask; C Ronalds; E Downes-Grainger; H Thompson; D Goldberg
Journal:  Br J Gen Pract       Date:  1999-04       Impact factor: 5.386

5.  Common mental disorders in primary health care: differences between Latin American-born and Spanish-born residents in Madrid, Spain.

Authors:  Miguel A Salinero-Fort; Rodrigo Jiménez-García; Carmen de Burgos-Lunar; Rosa M Chico-Moraleja; Paloma Gómez-Campelo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-10-02       Impact factor: 4.328

6.  Prevalence of somatisation and psychologisation among patients visiting primary health care centres in the State of Qatar.

Authors:  Abdulbari Bener; Suhaila Ghuloum; Ahmed A K Al-Mulla; Saleh Al-Marri; Mohammed S Hashim; Isam-Eldin A Elbagi
Journal:  Libyan J Med       Date:  2010-06-16       Impact factor: 1.657

Review 7.  Beyond somatisation: a review of the understanding and treatment of medically unexplained physical symptoms (MUPS).

Authors:  Christopher Burton
Journal:  Br J Gen Pract       Date:  2003-03       Impact factor: 5.386

8.  Cognitive-behaviour therapy for patients with Abridged Somatization Disorder (SSI 4,6) in primary care: a randomized, controlled study.

Authors:  Rosa Magallón; Margalida Gili; Sergio Moreno; Natalia Bauzá; Javier García-Campayo; Miquel Roca; Yolanda Ruiz; Eva Andrés
Journal:  BMC Psychiatry       Date:  2008-06-22       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.